AAIC 2017 | Targeting the asymptomatic: the DIAN-TU trial
Tammie Benzinger, MD, PhD from Washington University in St. Louis School of Medicine, St. Louis, MO speaks to us about DIAN-TU (NCT01760005), a clinical trial which targets patients of dominantly inherited Alzheimer’s disease who are asymptomatic. Dr Benzinger explains the methodology of the trial, its goals and the future work that is planned. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.
Get great new content delivered to your inboxSign up